Flovent Powder, Metered
Product Images NDC 50090-1245

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 50090-1245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Flovent Diskus Spl Graphic 01)

Chemical Structure (Flovent Diskus Spl Graphic 01)
Chemical structure diagram of fluticasone propionate showing the detailed molecular arrangement and bonding of atoms in the active ingredient.*
FDA Label Image

Figure 1. A 12-week Clinical Trial Evaluating Flovent Diskus 100 Mcg Twice Daily In Adults And Adolescents Receiving Bronchodilators Alone (Flovent Diskus Spl Graphic 02)

Figure 1. A 12-week Clinical Trial Evaluating Flovent Diskus 100 Mcg Twice Daily In Adults And Adolescents Receiving Bronchodilators Alone (Flovent Diskus Spl Graphic 02)
A line graph showing percentage change from baseline in FEV1 over 12 weeks comparing FLOVENT DISKUS 100 mcg twice daily and placebo. The x-axis represents time in weeks and the endpoint, while the y-axis shows percent change. FLOVENT DISKUS consistently shows a higher improvement in FEV1 than placebo throughout the study period.*
FDA Label Image

Figure 2. A 12-week Clinical Trial Evaluating Flovent Diskus 100 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids (Flovent Diskus Spl Graphic 03)

Figure 2. A 12-week Clinical Trial Evaluating Flovent Diskus 100 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids (Flovent Diskus Spl Graphic 03)
Line graph showing the percentage change from baseline in FEV1 over a 12-week period for FLOVENT DISKUS 100 mcg twice daily compared to placebo. The graph plots weeks on the x-axis and percentage change in FEV1 on the y-axis, illustrating higher improvement with FLOVENT DISKUS versus placebo across the study duration.*
FDA Label Image

Figure 3. A 12-week Clinical Trial Evaluating Flovent Diskus 250 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids Or Bronchodilators Alone (Flovent Diskus Spl Graphic 04)

Figure 3. A 12-week Clinical Trial Evaluating Flovent Diskus 250 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids Or Bronchodilators Alone (Flovent Diskus Spl Graphic 04)
Line graph showing percent change from baseline in FEV1 over 12 weeks comparing FLOVENT DISKUS 250 mcg twice daily with placebo. The x-axis represents weeks, and the y-axis shows percent change. FLOVENT DISKUS demonstrates a higher and more sustained increase in FEV1 compared to placebo throughout the study period.*
FDA Label Image

Figure 4. A 12-week Clinical Trial Evaluating Flovent Diskus 500 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids Or Bronchodilators Alone (Flovent Diskus Spl Graphic 05)

Figure 4. A 12-week Clinical Trial Evaluating Flovent Diskus 500 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids Or Bronchodilators Alone (Flovent Diskus Spl Graphic 05)
Line graph depicting the percentage change from baseline in FEV1 over 12 weeks, comparing FLOVENT DISKUS 500 mcg twice daily versus placebo. The x-axis represents weeks, and the y-axis shows percent change in FEV1. FLOVENT DISKUS shows consistently higher improvement than placebo across all weeks.*
FDA Label Image

Figure A (Flovent Diskus Spl Graphic 06)

Figure A (Flovent Diskus Spl Graphic 06)
Illustration of a FloVent Diskus inhaler showing labeled parts including outer case, mouthpiece, lever, thumb grip, and dose counter. The device dispenses fluticasone propionate inhalation powder 100 mcg in a powder, metered form for respiratory inhalation.*
FDA Label Image

Figure B (Flovent Diskus Spl Graphic 07)

Figure B (Flovent Diskus Spl Graphic 07)
An instructional illustration depicting a hand holding a Flovent Diskus inhaler, showing the motion of sliding the device open for use. The image focuses on demonstrating how to prepare the inhaler for inhalation of fluticasone propionate powder.*
FDA Label Image

Figure C (Flovent Diskus Spl Graphic 08)

Figure C (Flovent Diskus Spl Graphic 08)
An instructional illustration showing a hand holding a Flovent Diskus inhaler, demonstrating how to operate the device by sliding the lever to release a dose. The image emphasizes the inhaler's design and user interaction.*
FDA Label Image

Figure D (Flovent Diskus Spl Graphic 09)

Figure D (Flovent Diskus Spl Graphic 09)
Illustration of a woman demonstrating the use of a FLOVENT DISKUS inhaler by holding it ready for inhalation. The image shows the inhalation process for the powder metered respiratory drug fluticasone propionate by A-S Medication Solutions.*
FDA Label Image

Figure E (Flovent Diskus Spl Graphic 10)

Figure E (Flovent Diskus Spl Graphic 10)
An illustration showing a woman using a red Flovent Diskus inhaler device for respiratory inhalation. The image demonstrates the proper positioning of the inhaler at the mouth, emphasizing its use for administering metered powder medication.*
FDA Label Image

Figure F (Flovent Diskus Spl Graphic 11)

Figure F (Flovent Diskus Spl Graphic 11)
An instructional illustration showing hands holding a FLOVENT DISKUS inhaler. The image includes an arrow indicating the direction to slide the lever to prepare the inhaler for use. The device is round and orange, typical of a powder metered dose inhaler for respiratory administration.*
FDA Label Image

Figure G (Flovent Diskus Spl Graphic 12)

Figure G (Flovent Diskus Spl Graphic 12)
An illustration showing a woman rinsing her mouth with water over a sink, with a glass of water placed nearby. The image likely depicts a step related to oral hygiene or medication use involving rinsing.*
FDA Label Image

Figure H (Flovent Diskus Spl Graphic 13)

Figure H (Flovent Diskus Spl Graphic 13)
FLOVENT DISKUS 100 mcg powder, metered inhalation device. The circular label on the diskus indicates it contains 60 blisters totaling 100 doses. The label includes the generic name fluticasone propionate inhalation powder and dosage strength 100 mcg. The reddish-brown, curved plastic inhaler is designed for respiratory use.*
FDA Label Image

Label Image (Lbl500901245)

Label Image (Lbl500901245)
Flovent Diskus 50 mcg powder inhalation blister packaging label by A-S Medication Solutions. It contains 60 metered doses per container. The label includes storage instructions to keep the product between 68 to 77 degrees Fahrenheit away from direct heat or sunlight, and provides the product number 6265-0 along with an NDC 50090-1245-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.